Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Impact of NPAS2 on mPFC dopamine synthesis and nap behavior

ABSTRACT: The biological basis of afternoon nap, a widespread yet poorly understood phenomenon, has remained elusive. Here we identify NPAS2, among core circadian regulators, as a sex-independent determinant of the nap behavior in mice. Specifically, medial prefrontal cortex (mPFC)-expressed NPAS2 orchestrates nap regulation through circadian modulation of local dopaminergic activity. We demonstrate that tyrosine hydroxylase-positive (TH+) neurons in mPFC exhibit time-of-day dependent wake-promoting activity, showing minimal excitation precisely during nap hours. Mechanistically, NPAS2 achieves this circadian suppression through a POU2F2-TH regulatory pathway: 1) transcriptional activation of the transcription repressor POU2F2, and 2) consequent downregulation of TH expression (a rate-limiting enzyme for dopamine synthesis) and dopamine production in mPFC TH+ neurons. These findings establish an endogenous circadian mechanism where mPFC NPAS2 periodically inhibits wake-promoting dopaminergic activity to drive nap behavior, providing fundamental insights into the neural and molecular regulation of nap biology.

ORGANISM(S): Mus musculus

PROVIDER: GSE317892 | GEO | 2026/01/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Impact of NPAS2 on mPFC dopamine synthesis and nap behavior

Project description:Impact of NPAS2 on mPFC dopamine synthesis and nap behavior

| PRJNA1415761 | ENA

NAP provides neuroprotection against kainic acid-induced cell death

Project description:NAP - neuroprotective peptide demonstrates increase in neuronal survival when injected into the hippocampus of rats in the model of epilepsy Microarray analysis was used to understand the expression of genes following KA treatment and the changes in gene expression following KA+NAP treatment Keywords: stress response KA was injected into the hippocampus of Sprague-Dawley rats. The other group of rats was injected with KA and NAP(10-13M). The third group was injected with NAP only and the last group was injected with PBS as a vehicle. CA3 area of hippocampus was removed 24h later and RNA extraction was done. The samples were subjected to microarray analysis.

2010-04-06 | E-GEOD-10923 | biostudies-arrayexpress

Transcriptomic profiling of mouse colorectal organoids following NAP treatment.

Project description:Bisphenol F (BPF) is a widely used substitute for bisphenol A (BPA) in plastic manufacturing; however, its potential toxicity remains insufficiently characterized. In this study, we investigated the impact of BPF exposure on the intestinal barrier and cardiovascular system. Based on prior untargeted metabolomic analysis, we revealed that BPF can be converted into N-acetylputrescine (NAP) through a microbiota-associated metabolic process. Further experiments demonstrated that BPF exposure stimulated intestinal epithelial cells to secrete spermidine/spermine N1-acetyltransferase 1 (Sat1), an enzyme involved in this conversion. To explore the molecular mechanisms underlying NAP-induced effects, we performed RNA sequencing on mouse colorectal organoids treated with NAP. Transcriptomic analysis was conducted to identify gene expression changes and signaling pathways associated with NAP exposure. The raw sequencing data and processed expression matrices are provided in this submission.

2026-03-15 | GSE324667 | GEO

NAP provides neuroprotection against kainic acid-induced cell death

2010-03-01 | GSE10923 | GEO

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration

Project description:Circadian rhythm dysfunction is a hallmark of Parkinson Disease (PD), and diminished expression of the core clock gene Bmal1 has been described in PD patients. BMAL1 is required for core circadian clock function, but also serves non-rhythmic functions. Germline Bmal1 deletion can cause brain oxidative stress and synapse loss in mice, and can exacerbate dopaminergic neurodegeneration in response to MPTP. Here we examined the impact of cell type-specific Bmal1 deletion on dopaminergic neuron viability in vivo. We observed that global, post-natal deletion of Bmal1 caused spontaneous loss of tyrosine hydroxylase-positive (TH+) dopaminergic neurons in the substantia nigra pars compacta (SNpc). This was not due to disruption of behavioral circadian rhythms, and was not induced by astrocyte- or microglia-specific Bmal1 deletion. However, either pan-neuronal or TH neuron-specific Bmal1 deletion caused cell-autonomous loss of TH+ neurons in the SNpc. Finally, global Bmal1 deletion exacerbated TH+ neuron loss following injection of alpha-synclein fibrils. Transcriptomic analysis of neuron-specific Bmal1 KO brain revealed dysregulation of pathways involved in oxidative phosphorylation and Parkinson Disease.

2023-08-18 | GSE241200 | GEO

Nucleosome assembly protein-1 (NAP-1) is regulator of histone H1 acetylation

Project description:We identified NAP-1 as regulator of histone H1 acetyation.

2020-10-10 | GSE159294 | GEO

MO-OH-Nap and SAHA induce distinct patterns of gene expression in the multiple myeloma cell line U266.

Project description:Tropolones are small organic compounds with metal-directing moieties. Functionally, tropolones inhibit the proliferation of cancer cell lines, possibly through the inhibition of metalloenzymes such as select histone deacetylases (HDACS). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma albeit with significant side-effects likely owning to their lack of specificity. It was therefore hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel a-substituted tropolones were evaluated for cytotoxic effects in multiple myeloma cells. While all tested tropolones showed some level of toxicity, MO-OH-Nap had consistently low EC50 values between 1-11 mM in all three cell lines tested and was used for subsequent experiments. MO-OH-Nap was found to induce apoptosis in a concentration-dependent manner. Time course experiments demonstrated that MO-OH-Nap promotes caspase cleavage in a time-frame that was distinct from the pan-HDAC inhibitor SAHA. Furthermore, MO-OH-Nap- and SAHA-treated cells possess unique gene expression patterns, suggesting they promote apoptosis via different mechanisms. In particular, MO-OH-Nap increases the expression of markers associated with endoplasmic reticulum stress and the unfolded protein response. Synergistic cytotoxic effects were observed when cells were treated with the combination of MO-OH-Nap and the proteasome inhibitor bortezomib. However, treatment with MO-OH-Nap did not abrogate the bortezomib-induced increase in aggresomes, consistent with an HDAC6-independent mechanism for the observed synergy. Collectively, these finding support further investigation into the usefulness of a-substituted tropolones as anti-myeloma agents.

2018-01-01 | GSE93099 | GEO

NPAS2 ChIP-on-chip in MCF7 cells

Project description:The aim of the current study is to create a transcriptional profile of genes regulated by the circadian gene NPAS2, using a human binding ChIP-on-chip analysis of NPAS2 in MCF-7 cells.

2009-03-07 | GSE15052 | GEO

Blastopirellula marina strain:Nap-Phe MGV

Project description:Blastopirellula marina strain:Nap-Phe MGV Genome sequencing and assembly

| PRJNA435595 | ENA

Blastopirellula marina strain:NAP PRIS-MGV

Project description:Blastopirellula marina strain:NAP PRIS-MGV Genome sequencing and assembly

| PRJNA435608 | ENA